2012
DOI: 10.1016/j.bmcl.2012.03.087
|View full text |Cite
|
Sign up to set email alerts
|

S-Adenosylhomocysteine hydrolase of the protozoan parasite Trichomonas vaginalis: Potent inhibitory activity of 9-(2-deoxy-2-fluoro-β,d-arabinofuranosyl)adenine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…TvagENT3 is functionally related to the broad specificity T. brucei P1‐type transporters (De Koning & Jarvis, 1999), although the relatively high affinity for cytidine may be unique amongst protozoan transporters characterized to date, and like P1, its broad specificity/high affinity should be valuable in targeting cytotoxic nucleoside analogues to the T. vaginalis interior (Geiser et al., 2005; Hulpia et al., 2019; Ranjbarian et al., 2017). Indeed, we have very recently reported the identification of a series of strongly antitrichomonal nucleoside analogues (Natto et al., 2021) and other nucleoside analogues with activity against this parasite have been reported (Munagala & Wang, 2003; Shokar et al., 2012).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…TvagENT3 is functionally related to the broad specificity T. brucei P1‐type transporters (De Koning & Jarvis, 1999), although the relatively high affinity for cytidine may be unique amongst protozoan transporters characterized to date, and like P1, its broad specificity/high affinity should be valuable in targeting cytotoxic nucleoside analogues to the T. vaginalis interior (Geiser et al., 2005; Hulpia et al., 2019; Ranjbarian et al., 2017). Indeed, we have very recently reported the identification of a series of strongly antitrichomonal nucleoside analogues (Natto et al., 2021) and other nucleoside analogues with activity against this parasite have been reported (Munagala & Wang, 2003; Shokar et al., 2012).…”
Section: Discussionmentioning
confidence: 98%
“…This makes the parasites vulnerable to inhibitors of key enzymes of the nucleoside salvage pathways and to subversive substrates. Nucleoside analogues with strong antitrichomonal activity have been identified and include formycin A (Munagala & Wang, 2003), adenine arabinoside, 2′‐F,2′‐deoxyadenosine, and 2′‐F,2′‐deoxyarabinoadenosine (Shokar et al., 2012). Very recently, we reported on a range of 7‐substituted,7‐deazaadenosine analogues with mid‐nanomolar activity against T. vaginalis in vitro and one compound, 7‐(4‐Cl‐phenyl),7‐deazaadenosine, was shown to be efficacious in a murine model of vaginal trichomonad infection (Natto et al., 2021).…”
Section: Introductionmentioning
confidence: 99%
“…The lack of efficacy observed with the 5′-norcarbocyclic uridine analogues is consistent with a study that reported little or no inhibition of T . vaginalis growth with modified uridine analogues, but that same study did identify some adenosine analogues, including adenine arabinoside, 2′-F,2′-deoxy­adenosine, and 2′-deoxy-2′-fluoro­arabino­adenosine, with substantial antitrichomonal efficacy . In addition, it was shown that 2-F,2′-deoxy­adenosine is a substrate of T .…”
Section: Discussionmentioning
confidence: 99%
“…Nucleosides bearing fluorine or fluorinated substituents within the carbohydrate moiety have been used successfully in many biochemical research studies and therapeutic treatments. As an example, the ability of 9-(2-deoxy-β-D-arabinofuranosyl)adenine to completely inhibit the protozoan parasite Trichomonas vaginalis (Shokar et al, 2012), as well as its antibacterial (Gao et al, 2015) and antitrypanosomal (Ranjbarian et al, 2017) effect, have been reported. Significant antiviral activity was also confirmed for their dideoxy analogs.…”
Section: Discussionmentioning
confidence: 99%